Rituximab-induced Hypogammaglobulinemia and Infection Risk in Pediatric Patients

Risk of infection in patients with atopic dermatitis treated with dupilumab: A meta-analysis of randomized controlled trials

J Am Acad Dermatol.

Fleming P, Drucker AM

doi: 10.1016/j.jaad.2017.09.052.

Rheumatoid Arthritis

Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease

Clin Rheumatol.

Zamora-Legoff JA, Krause ML, Crowson CS, Ryu JH, Matteson EL

doi: 10.1007/

Further Publications Rheumatology

Valvular and infection-associated risk factors as criteria to guide the use of echocardiography in patients with native joint infections

Semin Arthritis Rheum

Beaufrère M, Pressat-Laffouilhère T, Marcelli C, Michon J, Lequerré T, Prum-Delépine C, Fiaux E, Rasoldier V, Etienne M, Savouré A, Dormoy L, Dargère S, Verdon R, Vittecoq O, Avenel G

doi: 10.1016/j.semarthrit.2021.08.008

Autoimmune Disease

Severe infections in patients with ANCA associated vasculitis treated with rituximab

Rheumatology (Oxford)

Segelmark L, Flores-Suárez LF, Mohammad AJ

doi: 10.1093/rheumatology/keab293

Rheumatoid Arthritis

Risk of serious infections in tocilizumab versus other biologic drugs in patients with rheumatoid arthritis: a multidatabase cohort study

Ann Rheum Dis.

Pawar A, Desai RJ, Solomon DH, Santiago Ortiz AJ, Gale S, Bao M, Sarsour K, Schneeweiss S, Kim SC

doi: 10.1136/annrheumdis-

Psoriasis

Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the United Kingdom and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Br J Dermatol.

Yiu ZZN, Ashcroft DM, Evans I, McElhone K, Lunt M, Smith CH, Walton S, Murphy R, Reynolds NJ, Ormerod AD, Griffiths CEM, Warren RB; BADBIR Study Group

doi: 10.1111/bjd.17036.

Further Publications Rheumatology

Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model

Rheumatology (Oxford)

Krabbe S, Grøn KL, Glintborg B, Nørgaard M, Mehnert F, Jarbøl DE, Østergaard M, Hetland ML

doi: 10.1093/rheumatology/keaa876

Psoriasis

Risk of Serious Infection in Patients Receiving Systemic Medications for the Treatment of Psoriasis

JAMA Dermatol.

Dommasch ED, Kim SC, Lee MP, Gagne JJ

doi: 10.1001/jamadermatol.

Rheumatoid ArthritisSpinal Disorders

Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis

Arthritis Res Ther.

Vinson D, Molet-Benhamou L, Degboé Y, den Broeder A, Ibrahim F, Pontes C, Westhovens R, Závada J, Pham T, Barnetche T, Constantin A, Ruyssen-Witrand A

doi: 10.1186/s13075-020-02188-x.

Related content